Agilent Technologies (NYSE:A) posted its quarterly earnings data on Wednesday. The medical research company reported $0.76 EPS for the quarter, beating the Zacks’ consensus estimate of $0.72 by $0.04, RTT News reports. The company had revenue of $1.27 billion for the quarter, compared to analyst estimates of $1.24 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The company’s quarterly revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.67 EPS.
A traded down $2.05 during trading on Wednesday, hitting $65.59. 3,508,500 shares of the company’s stock were exchanged, compared to its average volume of 2,303,427. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35. The firm’s 50 day moving average price is $70.86. Agilent Technologies has a fifty-two week low of $61.01 and a fifty-two week high of $82.27. The company has a market cap of $21.47 billion, a PE ratio of 23.51, a P/E/G ratio of 1.91 and a beta of 1.41.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were issued a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, July 1st. This represents a $0.66 annualized dividend and a yield of 1.00%. Agilent Technologies’s payout ratio is 23.66%.
Several brokerages recently issued reports on A. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Friday, July 12th. Piper Jaffray Companies began coverage on shares of Agilent Technologies in a research note on Tuesday, June 11th. They set an “overweight” rating and a $83.00 target price on the stock. Wolfe Research began coverage on shares of Agilent Technologies in a research note on Thursday, May 30th. They set a “peer perform” rating on the stock. Barclays lowered shares of Agilent Technologies from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $86.00 to $78.00 in a research note on Monday, July 15th. Finally, Zacks Investment Research lowered shares of Agilent Technologies from a “hold” rating to a “sell” rating and set a $71.00 target price on the stock. in a research note on Tuesday, July 16th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and ten have given a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $83.92.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Recommended Story: What does a bar chart display?
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.